Literature DB >> 7675957

Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures.

A Francis1, L Fochtmann.   

Abstract

A variety of neurotransmitter receptor changes occur after a course of electroconvulsive seizures (ECS) in rats, including an increased density of adenosine A1 sites. Adenosine antagonism has been related to the proconvulsant action of methylxanthines such as caffeine. We determined tonic-clonic seizure duration in rats given ECS with caffeine (0-175 mg/kg, IP) after a course of one or six daily ECS. A single day of ECS did not affect the dose-dependent proconvulsant action of caffeine. After six daily ECS, the proconvulsant action of caffeine was reduced. After nine daily ECS, an A1 antagonist (8-cyclopentyl-1,3-dipropylxanthine) and an A2A antagonist (1-allyl-3,7-dimethyl-8-p-sulfophenylxanthine) showed reduced proconvulsant activity. The results suggest that the reduced proconvulsant action of caffeine after chronic ECS depends on adenosine antagonism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675957     DOI: 10.1007/bf02246060

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  Alterations of A1 adenosine receptors in different mouse brain areas after pentylentetrazol-induced seizures, but not in the epileptic mutant mouse 'tottering'.

Authors:  F Angelatou; O Pagonopoulou; G Kostopoulos
Journal:  Brain Res       Date:  1990-11-26       Impact factor: 3.252

2.  Pharmacological manipulation of ECT-induced seizure duration.

Authors:  B Lerer; B Shapira; H Drexler; A Calev; M E Newman
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

3.  Functional coupling of human adenosine receptors to a ligand-dependent reporter gene system.

Authors:  M J Castañón; W Spevak
Journal:  Biochem Biophys Res Commun       Date:  1994-01-28       Impact factor: 3.575

Review 4.  Chronic electroconvulsive shock and neurotransmitter receptors--an update.

Authors:  C H Gleiter; D J Nutt
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

Review 5.  Clinical pharmacology of caffeine.

Authors:  N L Benowitz
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

6.  Caffeine Pretreatment Enhances Clinical Efficacy and Reduces Cognitive Effects of Electroconvulsive Therapy.

Authors:  Avraham Calev; Max Fink; Georgios Petrides; Andrew Francis; Laura Fochtmann
Journal:  Convuls Ther       Date:  1993

7.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.

Authors:  T V Dunwiddie; B B Fredholm
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

Review 8.  Basic and clinical aspects of adenosinergic neuromodulation.

Authors:  P J Marangos; J P Boulenger
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

9.  Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats.

Authors:  J M Carney
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

10.  Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

Authors:  J Baumgold; O Nikodijevic; K A Jacobson
Journal:  Biochem Pharmacol       Date:  1992-02-18       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.